T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Charles Schwab
SCHW
|
$2.18B |
| 2 |
Airbnb
ABNB
|
$1.59B |
| 3 |
Goldman Sachs
GS
|
$1.35B |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
$1.27B |
| 5 |
Caterpillar
CAT
|
$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
$2.44B |
| 2 |
Qualcomm
QCOM
|
$1.64B |
| 3 |
Becton Dickinson
BDX
|
$1.61B |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
$1.43B |
| 5 |
Fidelity National Information Services
FIS
|
$1.04B |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.91% |
| 4 | Financials | 12.32% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Estee Lauder
EL
$32.1B
| $788M | 0.08% |
2,958,941
+336,491
| +13% | +$89.6M |
|
252
KKR & Co
KKR
$121B
| $787M | 0.08% |
19,445,849
+1,307,316
| +7% | +$52.9M |
|
253
Perrigo
PRGO
$3.12B
| $786M | 0.08% |
17,586,621
-369,076
| -2% | -$16.5M |
|
254
Alcon
ALC
$39.6B
| $783M | 0.08% |
11,815,454
-3,154,826
| -21% | -$209M |
|
255
QuidelOrtho
QDEL
$1.95B
| $766M | 0.08% |
4,261,838
+25,123
| +0.6% | +$4.51M |
|
256
FirstService
FSV
$9.18B
| $761M | 0.08% |
5,567,958
+297,715
| +6% | +$40.7M |
|
257
AT&T
T
$212B
| $760M | 0.08% |
34,997,051
+361,222
| +1% | +$7.85M |
|
258
Assurant
AIZ
$10.7B
| $756M | 0.08% |
5,550,022
-13,036
| -0.2% | -$1.78M |
|
259
MongoDB
MDB
$26.4B
| $756M | 0.08% |
2,105,487
+554,855
| +36% | +$199M |
|
260
Sealed Air
SEE
$4.82B
| $756M | 0.08% |
16,503,647
+2,071,560
| +14% | +$94.9M |
|
261
Array Technologies
ARRY
$1.37B
| $754M | 0.08% |
+17,488,800
| New | +$754M |
|
262
Okta
OKTA
$16.1B
| $754M | 0.08% |
2,967,120
-1,210,300
| -29% | -$308M |
|
263
Willis Towers Watson
WTW
$32.1B
| $746M | 0.08% |
3,550,676
-1,940,702
| -35% | -$408M |
|
264
Ionis Pharmaceuticals
IONS
$9.76B
| $742M | 0.08% |
13,114,967
+2,382,942
| +22% | +$135M |
|
|
XLNX
265
DELISTED
Xilinx Inc
XLNX
| $739M | 0.08% |
5,209,862
-4,325,454
| -45% | -$613M |
|
266
MGM Resorts International
MGM
$9.98B
| $728M | 0.07% |
23,101,348
-15,879,755
| -41% | -$500M |
|
267
Alnylam Pharmaceuticals
ALNY
$59.2B
| $725M | 0.07% |
5,575,342
-439,509
| -7% | -$57.1M |
|
|
ZNGA
268
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $716M | 0.07% |
72,558,078
+12,330,586
| +20% | +$122M |
|
269
Amgen
AMGN
$153B
| $704M | 0.07% |
3,060,349
-525,306
| -15% | -$121M |
|
|
NVRO
270
DELISTED
NEVRO CORP.
NVRO
| $697M | 0.07% |
4,028,320
-535,455
| -12% | -$92.7M |
|
271
Pinduoduo
PDD
$177B
| $694M | 0.07% |
3,906,773
+3,888,813
| +21,653% | +$691M |
|
272
Broadridge
BR
$29.4B
| $688M | 0.07% |
4,492,464
+1,105,360
| +33% | +$169M |
|
273
Skyworks Solutions
SWKS
$11.2B
| $685M | 0.07% |
4,482,766
-13,200
| -0.3% | -$2.02M |
|
274
Capital One
COF
$142B
| $683M | 0.07% |
6,907,496
-6,710,888
| -49% | -$663M |
|
|
XLRN
275
DELISTED
Acceleron Pharma Inc.
XLRN
| $679M | 0.07% |
5,309,766
+114,393
| +2% | +$14.6M |
|